Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: F32 HL162231
NHLBI NIH HHS
Grant: K08 HL146990
NHLBI NIH HHS
Grant: K24 HL133373
NHLBI NIH HHS
Grant: R01 HL092173
National Institutes of Health
Grant: 1F32HL162231-01A1
Bleeding on Direct Oral Anticoagulants: Identification of Genetic Risk Factors and a Polygenic Predictive Score in Patients with Atrial Fibrillation
National Institutes of Health
Grant: 5K08HL146990-03
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy
Michigan Institute for Clinical and Health Research
National Heart, Lung, and Blood Institute
Fields of Study
Keywords
Sustainable Development Goals